Researchers found that an estimated 4.22 million people were living with glaucoma in the United States in 2022. HealthDay News — An estimated 2.56% of US adults ages 40 years and older have glaucoma, ...

Researchers found that the prevalence of abnormal screens for exposed vs unexposed offspring at age 12 months was 32.3% vs 29.4%.

The rate of sexual dysfunction among men with inflammatory bowel disease (IBD) has been reported to be between 44% and 53.9%, in which the most common type of male infertility was reported to be ...

Evidence suggests that patent ductus arteriosus comprises anywhere from 5% to 10% of all congenital heart disease.

Lumryz is an extended-release formulation of sodium oxybate, a central nervous system (CNS) depressant. Its therapeutic effects are believed to be mediated through GABA B actions at noradrenergic and ...

C, is a University of Georgia alumna. She recently graduated from the Augusta University Physician Assistant program and became board certified.

Credit: Getty Images. The Clinical Advisor asked May Koslap-Petraco, DNP PPCNP-BC CPNP FAANP, a pediatric nurse practitioner, ...

Two patients present with hyperpigmented patches on their face and neck. Can you correctly identify each case?

Prescriptions for GLP-1 RAs less common among White teens vs Black, Hispanic teens. HealthDay News — Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 ...

Ultraprocessed food (UPF) intake accounts for nearly half of toddlers’ energy and increases in mid-childhood, according to a study published online in the Eur ...

The Food and Drug Administration (FDA) has approved Imuldosa ™ (ustekinumab-srlf), a biosimilar to Stelara ® (ustekinumab), for the treatment of various chronic inflammatory diseases. Imuldosa, ...

Itovebi is supplied as a tablet in 2 dosage strengths: 3 mg and 9 mg. Patients should be selected for treatment based on the presence of 1 or more PIK3CA mutations in plasma specimens. The FDA has ...